Cargando…
The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda
INTERVENTION: Few studies have documented the interruption of onchocerciasis and Lymphatic Filariasis (LF) by integrated chemotherapy in Uganda. The study describes the interruption of transmission of the two diseases co-endemic in Obongi focus, north western Uganda. Base line data for Onchocerciasi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734780/ https://www.ncbi.nlm.nih.gov/pubmed/29253862 http://dx.doi.org/10.1371/journal.pone.0189306 |
_version_ | 1783287105527480320 |
---|---|
author | Luroni, Lakwo Thomson Gabriel, Matwale Tukahebwa, Edridah Onapa, Ambrose Winston Tinkitina, Benjamin Tukesiga, Ephraim Nyaraga, Michael Auma, Anna Mary Habomugisha, Peace Byamukama, Edson Oguttu, David Katabarwa, Moses Unnasch, Thomas Raymond |
author_facet | Luroni, Lakwo Thomson Gabriel, Matwale Tukahebwa, Edridah Onapa, Ambrose Winston Tinkitina, Benjamin Tukesiga, Ephraim Nyaraga, Michael Auma, Anna Mary Habomugisha, Peace Byamukama, Edson Oguttu, David Katabarwa, Moses Unnasch, Thomas Raymond |
author_sort | Luroni, Lakwo Thomson |
collection | PubMed |
description | INTERVENTION: Few studies have documented the interruption of onchocerciasis and Lymphatic Filariasis (LF) by integrated chemotherapy in Uganda. The study describes the interruption of transmission of the two diseases co-endemic in Obongi focus, north western Uganda. Base line data for Onchocerciasis and LF were collected in 1994 and 2006, respectively. Annual mass drug administration for onchocerciasis (Ivermectin) and Lymphatic Filariasis (Ivermectin + albendazole) was conducted for 20 and 6 years, respectively. Thereafter, assessments by skin snip, larval searches in rivers and human landing catches were performed. Children <10 years were screened for IgG4 antibodies using Ov16 ELISA technique in 2013. LF Pre-TAS and TAS1 were conducted in sentinel sites. ITN coverage and utilization for the implementation unit was also reported. INTERVENTION COVERAGE: Onchocerciasis treatment coverage was <80% but improved with the introduction of CDTI in 1999. While for LF, effective coverage of >65% was achieved in the six treatment rounds. Household ownership of ITN’s and utilization was 96% and 72.4%., respectively. IMPACT: Parasitological examinations conducted for onchocerciasis among 807 adults and children, revealed a reduction in mf prevalence from 58% in 1994 to 0% in 2012. Entomological monitoring conducted at the two sites had no single Simulium damnosum fly caught. Serological analysis using Ov16 ELISA for onchocerciasis revealed that out of the 3,308 children <10 years old screened in 2013, only 3/3308 (0.091%) positive cases were detected. All Ov16 positive children were negative when tested for patent infection by skin snip PCR. A reduction in LF microfilaria prevalence from 2.5% (n = 13/522) in 2006 to 0.0% (n = 602) in 2014 was observed. LF TAS1 conducted in 2015 among 1,532 children 6–7 years, all were negative for antigens of W. bancrofti. CONCLUSION: The results concluded that interruption of onchocerciasis and LF has been achieved. |
format | Online Article Text |
id | pubmed-5734780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-57347802017-12-22 The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda Luroni, Lakwo Thomson Gabriel, Matwale Tukahebwa, Edridah Onapa, Ambrose Winston Tinkitina, Benjamin Tukesiga, Ephraim Nyaraga, Michael Auma, Anna Mary Habomugisha, Peace Byamukama, Edson Oguttu, David Katabarwa, Moses Unnasch, Thomas Raymond PLoS One Research Article INTERVENTION: Few studies have documented the interruption of onchocerciasis and Lymphatic Filariasis (LF) by integrated chemotherapy in Uganda. The study describes the interruption of transmission of the two diseases co-endemic in Obongi focus, north western Uganda. Base line data for Onchocerciasis and LF were collected in 1994 and 2006, respectively. Annual mass drug administration for onchocerciasis (Ivermectin) and Lymphatic Filariasis (Ivermectin + albendazole) was conducted for 20 and 6 years, respectively. Thereafter, assessments by skin snip, larval searches in rivers and human landing catches were performed. Children <10 years were screened for IgG4 antibodies using Ov16 ELISA technique in 2013. LF Pre-TAS and TAS1 were conducted in sentinel sites. ITN coverage and utilization for the implementation unit was also reported. INTERVENTION COVERAGE: Onchocerciasis treatment coverage was <80% but improved with the introduction of CDTI in 1999. While for LF, effective coverage of >65% was achieved in the six treatment rounds. Household ownership of ITN’s and utilization was 96% and 72.4%., respectively. IMPACT: Parasitological examinations conducted for onchocerciasis among 807 adults and children, revealed a reduction in mf prevalence from 58% in 1994 to 0% in 2012. Entomological monitoring conducted at the two sites had no single Simulium damnosum fly caught. Serological analysis using Ov16 ELISA for onchocerciasis revealed that out of the 3,308 children <10 years old screened in 2013, only 3/3308 (0.091%) positive cases were detected. All Ov16 positive children were negative when tested for patent infection by skin snip PCR. A reduction in LF microfilaria prevalence from 2.5% (n = 13/522) in 2006 to 0.0% (n = 602) in 2014 was observed. LF TAS1 conducted in 2015 among 1,532 children 6–7 years, all were negative for antigens of W. bancrofti. CONCLUSION: The results concluded that interruption of onchocerciasis and LF has been achieved. Public Library of Science 2017-12-18 /pmc/articles/PMC5734780/ /pubmed/29253862 http://dx.doi.org/10.1371/journal.pone.0189306 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Luroni, Lakwo Thomson Gabriel, Matwale Tukahebwa, Edridah Onapa, Ambrose Winston Tinkitina, Benjamin Tukesiga, Ephraim Nyaraga, Michael Auma, Anna Mary Habomugisha, Peace Byamukama, Edson Oguttu, David Katabarwa, Moses Unnasch, Thomas Raymond The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda |
title | The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda |
title_full | The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda |
title_fullStr | The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda |
title_full_unstemmed | The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda |
title_short | The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda |
title_sort | interruption of onchocerca volvulus and wuchereria bancrofti transmission by integrated chemotherapy in the obongi focus, north western uganda |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734780/ https://www.ncbi.nlm.nih.gov/pubmed/29253862 http://dx.doi.org/10.1371/journal.pone.0189306 |
work_keys_str_mv | AT luronilakwothomson theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT gabrielmatwale theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT tukahebwaedridah theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT onapaambrosewinston theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT tinkitinabenjamin theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT tukesigaephraim theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT nyaragamichael theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT aumaannamary theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT habomugishapeace theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT byamukamaedson theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT oguttudavid theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT katabarwamoses theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT unnaschthomasraymond theinterruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT luronilakwothomson interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT gabrielmatwale interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT tukahebwaedridah interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT onapaambrosewinston interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT tinkitinabenjamin interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT tukesigaephraim interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT nyaragamichael interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT aumaannamary interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT habomugishapeace interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT byamukamaedson interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT oguttudavid interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT katabarwamoses interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda AT unnaschthomasraymond interruptionofonchocercavolvulusandwuchereriabancroftitransmissionbyintegratedchemotherapyintheobongifocusnorthwesternuganda |